img

Global Antiretroviral Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antiretroviral Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Antiretroviral Therapy report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antiretroviral Therapy market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antiretroviral Therapy industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antiretroviral Therapy key manufacturers include Gilead, F. Hoffmann-La Roche, ViiV Healthcare, Boehringer Ingelheim, Janssen Pharmaceuticals, Mylan, Abbvie, Bionor Pharma and Vertex Pharmaceuticals, etc. Gilead, F. Hoffmann-La Roche, ViiV Healthcare are top 3 players and held % sales share in total in 2022.
Antiretroviral Therapy can be divided into NNRTIs, NRTI, Multiclass Combination Products and Integrase Inhibitors, etc. NNRTIs is the mainstream product in the market, accounting for % sales share globally in 2022.
Antiretroviral Therapy is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Antiretroviral Therapy industry development. In 2022, global % sales of Antiretroviral Therapy went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antiretroviral Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Gilead
F. Hoffmann-La Roche
ViiV Healthcare
Boehringer Ingelheim
Janssen Pharmaceuticals
Mylan
Abbvie
Bionor Pharma
Vertex Pharmaceuticals
Segment by Type
NNRTIs
NRTI
Multiclass Combination Products
Integrase Inhibitors

Segment by Application


Hospital
Clinic
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antiretroviral Therapy market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antiretroviral Therapy, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antiretroviral Therapy industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antiretroviral Therapy in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antiretroviral Therapy introduction, etc. Antiretroviral Therapy Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antiretroviral Therapy market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Antiretroviral Therapy Market Overview
1.1 Antiretroviral Therapy Product Overview
1.2 Antiretroviral Therapy Market Segment by Type
1.2.1 NNRTIs
1.2.2 NRTI
1.2.3 Multiclass Combination Products
1.2.4 Integrase Inhibitors
1.3 Global Antiretroviral Therapy Market Size by Type
1.3.1 Global Antiretroviral Therapy Market Size Overview by Type (2018-2034)
1.3.2 Global Antiretroviral Therapy Historic Market Size Review by Type (2018-2024)
1.3.3 Global Antiretroviral Therapy Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antiretroviral Therapy Sales Breakdown by Type (2018-2024)
1.4.2 Europe Antiretroviral Therapy Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Antiretroviral Therapy Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Antiretroviral Therapy Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Antiretroviral Therapy Sales Breakdown by Type (2018-2024)
2 Global Antiretroviral Therapy Market Competition by Company
2.1 Global Top Players by Antiretroviral Therapy Sales (2018-2024)
2.2 Global Top Players by Antiretroviral Therapy Revenue (2018-2024)
2.3 Global Top Players by Antiretroviral Therapy Price (2018-2024)
2.4 Global Top Manufacturers Antiretroviral Therapy Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antiretroviral Therapy Market Competitive Situation and Trends
2.5.1 Antiretroviral Therapy Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Antiretroviral Therapy Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiretroviral Therapy as of 2022)
2.7 Date of Key Manufacturers Enter into Antiretroviral Therapy Market
2.8 Key Manufacturers Antiretroviral Therapy Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antiretroviral Therapy Status and Outlook by Region
3.1 Global Antiretroviral Therapy Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Antiretroviral Therapy Historic Market Size by Region
3.2.1 Global Antiretroviral Therapy Sales in Volume by Region (2018-2024)
3.2.2 Global Antiretroviral Therapy Sales in Value by Region (2018-2024)
3.2.3 Global Antiretroviral Therapy Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Antiretroviral Therapy Forecasted Market Size by Region
3.3.1 Global Antiretroviral Therapy Sales in Volume by Region (2024-2034)
3.3.2 Global Antiretroviral Therapy Sales in Value by Region (2024-2034)
3.3.3 Global Antiretroviral Therapy Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Antiretroviral Therapy by Application
4.1 Antiretroviral Therapy Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Antiretroviral Therapy Market Size by Application
4.2.1 Global Antiretroviral Therapy Market Size Overview by Application (2018-2034)
4.2.2 Global Antiretroviral Therapy Historic Market Size Review by Application (2018-2024)
4.2.3 Global Antiretroviral Therapy Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antiretroviral Therapy Sales Breakdown by Application (2018-2024)
4.3.2 Europe Antiretroviral Therapy Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Antiretroviral Therapy Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Antiretroviral Therapy Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Antiretroviral Therapy Sales Breakdown by Application (2018-2024)
5 North America Antiretroviral Therapy by Country
5.1 North America Antiretroviral Therapy Historic Market Size by Country
5.1.1 North America Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Antiretroviral Therapy Sales in Volume by Country (2018-2024)
5.1.3 North America Antiretroviral Therapy Sales in Value by Country (2018-2024)
5.2 North America Antiretroviral Therapy Forecasted Market Size by Country
5.2.1 North America Antiretroviral Therapy Sales in Volume by Country (2024-2034)
5.2.2 North America Antiretroviral Therapy Sales in Value by Country (2024-2034)
6 Europe Antiretroviral Therapy by Country
6.1 Europe Antiretroviral Therapy Historic Market Size by Country
6.1.1 Europe Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Antiretroviral Therapy Sales in Volume by Country (2018-2024)
6.1.3 Europe Antiretroviral Therapy Sales in Value by Country (2018-2024)
6.2 Europe Antiretroviral Therapy Forecasted Market Size by Country
6.2.1 Europe Antiretroviral Therapy Sales in Volume by Country (2024-2034)
6.2.2 Europe Antiretroviral Therapy Sales in Value by Country (2024-2034)
7 Asia-Pacific Antiretroviral Therapy by Region
7.1 Asia-Pacific Antiretroviral Therapy Historic Market Size by Region
7.1.1 Asia-Pacific Antiretroviral Therapy Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Antiretroviral Therapy Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Antiretroviral Therapy Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Antiretroviral Therapy Forecasted Market Size by Region
7.2.1 Asia-Pacific Antiretroviral Therapy Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Antiretroviral Therapy Sales in Value by Region (2024-2034)
8 Latin America Antiretroviral Therapy by Country
8.1 Latin America Antiretroviral Therapy Historic Market Size by Country
8.1.1 Latin America Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Antiretroviral Therapy Sales in Volume by Country (2018-2024)
8.1.3 Latin America Antiretroviral Therapy Sales in Value by Country (2018-2024)
8.2 Latin America Antiretroviral Therapy Forecasted Market Size by Country
8.2.1 Latin America Antiretroviral Therapy Sales in Volume by Country (2024-2034)
8.2.2 Latin America Antiretroviral Therapy Sales in Value by Country (2024-2034)
9 Middle East and Africa Antiretroviral Therapy by Country
9.1 Middle East and Africa Antiretroviral Therapy Historic Market Size by Country
9.1.1 Middle East and Africa Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Antiretroviral Therapy Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Antiretroviral Therapy Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Antiretroviral Therapy Forecasted Market Size by Country
9.2.1 Middle East and Africa Antiretroviral Therapy Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Antiretroviral Therapy Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Gilead
10.1.1 Gilead Company Information
10.1.2 Gilead Introduction and Business Overview
10.1.3 Gilead Antiretroviral Therapy Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Gilead Antiretroviral Therapy Products Offered
10.1.5 Gilead Recent Development
10.2 F. Hoffmann-La Roche
10.2.1 F. Hoffmann-La Roche Company Information
10.2.2 F. Hoffmann-La Roche Introduction and Business Overview
10.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Revenue and Gross Margin (2018-2024)
10.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Products Offered
10.2.5 F. Hoffmann-La Roche Recent Development
10.3 ViiV Healthcare
10.3.1 ViiV Healthcare Company Information
10.3.2 ViiV Healthcare Introduction and Business Overview
10.3.3 ViiV Healthcare Antiretroviral Therapy Sales, Revenue and Gross Margin (2018-2024)
10.3.4 ViiV Healthcare Antiretroviral Therapy Products Offered
10.3.5 ViiV Healthcare Recent Development
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Information
10.4.2 Boehringer Ingelheim Introduction and Business Overview
10.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Boehringer Ingelheim Antiretroviral Therapy Products Offered
10.4.5 Boehringer Ingelheim Recent Development
10.5 Janssen Pharmaceuticals
10.5.1 Janssen Pharmaceuticals Company Information
10.5.2 Janssen Pharmaceuticals Introduction and Business Overview
10.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Products Offered
10.5.5 Janssen Pharmaceuticals Recent Development
10.6 Mylan
10.6.1 Mylan Company Information
10.6.2 Mylan Introduction and Business Overview
10.6.3 Mylan Antiretroviral Therapy Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Mylan Antiretroviral Therapy Products Offered
10.6.5 Mylan Recent Development
10.7 Abbvie
10.7.1 Abbvie Company Information
10.7.2 Abbvie Introduction and Business Overview
10.7.3 Abbvie Antiretroviral Therapy Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Abbvie Antiretroviral Therapy Products Offered
10.7.5 Abbvie Recent Development
10.8 Bionor Pharma
10.8.1 Bionor Pharma Company Information
10.8.2 Bionor Pharma Introduction and Business Overview
10.8.3 Bionor Pharma Antiretroviral Therapy Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bionor Pharma Antiretroviral Therapy Products Offered
10.8.5 Bionor Pharma Recent Development
10.9 Vertex Pharmaceuticals
10.9.1 Vertex Pharmaceuticals Company Information
10.9.2 Vertex Pharmaceuticals Introduction and Business Overview
10.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Products Offered
10.9.5 Vertex Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antiretroviral Therapy Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antiretroviral Therapy Industrial Chain Analysis
11.4 Antiretroviral Therapy Market Dynamics
11.4.1 Antiretroviral Therapy Industry Trends
11.4.2 Antiretroviral Therapy Market Drivers
11.4.3 Antiretroviral Therapy Market Challenges
11.4.4 Antiretroviral Therapy Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antiretroviral Therapy Distributors
12.3 Antiretroviral Therapy Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of NNRTIs
Table 2. Major Company of NRTI
Table 3. Major Company of Multiclass Combination Products
Table 4. Major Company of Integrase Inhibitors
Table 5. Global Antiretroviral Therapy Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Antiretroviral Therapy Sales by Type (2018-2024) & (KG)
Table 7. Global Antiretroviral Therapy Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Antiretroviral Therapy Sales by Type (2018-2024) & (US& Million)
Table 9. Global Antiretroviral Therapy Market Share in Value by Type (2018-2024)
Table 10. Global Antiretroviral Therapy Price by Type (2018-2024) & (USD/KG)
Table 11. Global Antiretroviral Therapy Sales by Type (2024-2034) & (KG)
Table 12. Global Antiretroviral Therapy Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Antiretroviral Therapy Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Antiretroviral Therapy Sales Market Share in Value by Type (2024-2034)
Table 15. Global Antiretroviral Therapy Price by Type (2024-2034) & (USD/KG)
Table 16. North America Antiretroviral Therapy Sales by Type (2018-2024) & (KG)
Table 17. North America Antiretroviral Therapy Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Antiretroviral Therapy Sales (KG) by Type (2018-2024)
Table 19. Europe Antiretroviral Therapy Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Antiretroviral Therapy Sales (KG) by Type (2018-2024)
Table 21. Asia-Pacific Antiretroviral Therapy Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Antiretroviral Therapy Sales (KG) by Type (2018-2024)
Table 23. Latin America Antiretroviral Therapy Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Antiretroviral Therapy Sales (KG) by Type (2018-2024)
Table 25. Middle East and Africa Antiretroviral Therapy Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Antiretroviral Therapy Sales by Company (2018-2024) & (KG)
Table 27. Global Antiretroviral Therapy Sales Share by Company (2018-2024)
Table 28. Global Antiretroviral Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Antiretroviral Therapy Revenue Share by Company (2018-2024)
Table 30. Global Market Antiretroviral Therapy Price by Company (2018-2024) & (USD/KG)
Table 31. Global Antiretroviral Therapy Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiretroviral Therapy as of 2022)
Table 34. Date of Key Manufacturers Enter into Antiretroviral Therapy Market
Table 35. Key Manufacturers Antiretroviral Therapy Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Antiretroviral Therapy Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Antiretroviral Therapy Sales by Region (2018-2024) & (KG)
Table 39. Global Antiretroviral Therapy Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Antiretroviral Therapy Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Antiretroviral Therapy Sales Market Share in Value by Region (2018-2024)
Table 42. Global Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2018-2024)
Table 43. Global Antiretroviral Therapy Sales by Region (2024-2034) & (KG)
Table 44. Global Antiretroviral Therapy Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Antiretroviral Therapy Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Antiretroviral Therapy Sales Market Share in Value by Region (2024-2034)
Table 47. Global Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2024-2034)
Table 48. Global Antiretroviral Therapy Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Antiretroviral Therapy Sales by Application (2018-2024) & (KG)
Table 50. Global Antiretroviral Therapy Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Antiretroviral Therapy Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Antiretroviral Therapy Sales Market Share in Value by Application (2018-2024)
Table 53. Global Antiretroviral Therapy Price by Application (2018-2024) & (USD/KG)
Table 54. Global Antiretroviral Therapy Sales by Application (2024-2034) & (KG)
Table 55. Global Antiretroviral Therapy Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Antiretroviral Therapy Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Antiretroviral Therapy Sales Market Share in Value by Application (2024-2034)
Table 58. Global Antiretroviral Therapy Price by Application (2024-2034) & (USD/KG)
Table 59. North America Antiretroviral Therapy Sales by Application (2018-2024) (KG)
Table 60. North America Antiretroviral Therapy Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Antiretroviral Therapy Sales by Application (2018-2024) (KG)
Table 62. Europe Antiretroviral Therapy Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Antiretroviral Therapy Sales by Application (2018-2024) (KG)
Table 64. Asia-Pacific Antiretroviral Therapy Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Antiretroviral Therapy Sales by Application (2018-2024) (KG)
Table 66. Latin America Antiretroviral Therapy Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Antiretroviral Therapy Sales by Application (2018-2024) (KG)
Table 68. Middle East and Africa Antiretroviral Therapy Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Antiretroviral Therapy Sales by Country (2018-2024) & (KG)
Table 70. North America Antiretroviral Therapy Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Antiretroviral Therapy Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Antiretroviral Therapy Sales Market Share in Value by Country (2018-2024)
Table 73. North America Antiretroviral Therapy Sales by Country (2024-2034) & (KG)
Table 74. North America Antiretroviral Therapy Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Antiretroviral Therapy Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Antiretroviral Therapy Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Antiretroviral Therapy Sales by Country (2018-2024) & (KG)
Table 78. Europe Antiretroviral Therapy Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Antiretroviral Therapy Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Antiretroviral Therapy Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Antiretroviral Therapy Sales by Country (2024-2034) & (KG)
Table 82. Europe Antiretroviral Therapy Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Antiretroviral Therapy Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Antiretroviral Therapy Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Antiretroviral Therapy Sales by Region (2018-2024) & (KG)
Table 86. Asia-Pacific Antiretroviral Therapy Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Antiretroviral Therapy Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Antiretroviral Therapy Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Antiretroviral Therapy Sales by Region (2024-2034) & (KG)
Table 90. Asia-Pacific Antiretroviral Therapy Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Antiretroviral Therapy Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Antiretroviral Therapy Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Antiretroviral Therapy Sales by Country (2018-2024) & (KG)
Table 94. Latin America Antiretroviral Therapy Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Antiretroviral Therapy Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Antiretroviral Therapy Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Antiretroviral Therapy Sales by Country (2024-2034) & (KG)
Table 98. Latin America Antiretroviral Therapy Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Antiretroviral Therapy Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Antiretroviral Therapy Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Antiretroviral Therapy Sales by Country (2018-2024) & (KG)
Table 102. Middle East and Africa Antiretroviral Therapy Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Antiretroviral Therapy Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Antiretroviral Therapy Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Antiretroviral Therapy Sales by Country (2024-2034) & (KG)
Table 106. Middle East and Africa Antiretroviral Therapy Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Antiretroviral Therapy Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Antiretroviral Therapy Sales Market Share in Value by Country (2024-2034)
Table 109. Gilead Company Information
Table 110. Gilead Introduction and Business Overview
Table 111. Gilead Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2018-2024)
Table 112. Gilead Antiretroviral Therapy Product
Table 113. Gilead Recent Development
Table 114. F. Hoffmann-La Roche Company Information
Table 115. F. Hoffmann-La Roche Introduction and Business Overview
Table 116. F. Hoffmann-La Roche Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2018-2024)
Table 117. F. Hoffmann-La Roche Antiretroviral Therapy Product
Table 118. F. Hoffmann-La Roche Recent Development
Table 119. ViiV Healthcare Company Information
Table 120. ViiV Healthcare Introduction and Business Overview
Table 121. ViiV Healthcare Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2018-2024)
Table 122. ViiV Healthcare Antiretroviral Therapy Product
Table 123. ViiV Healthcare Recent Development
Table 124. Boehringer Ingelheim Company Information
Table 125. Boehringer Ingelheim Introduction and Business Overview
Table 126. Boehringer Ingelheim Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2018-2024)
Table 127. Boehringer Ingelheim Antiretroviral Therapy Product
Table 128. Boehringer Ingelheim Recent Development
Table 129. Janssen Pharmaceuticals Company Information
Table 130. Janssen Pharmaceuticals Introduction and Business Overview
Table 131. Janssen Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2018-2024)
Table 132. Janssen Pharmaceuticals Antiretroviral Therapy Product
Table 133. Janssen Pharmaceuticals Recent Development
Table 134. Mylan Company Information
Table 135. Mylan Introduction and Business Overview
Table 136. Mylan Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2018-2024)
Table 137. Mylan Antiretroviral Therapy Product
Table 138. Mylan Recent Development
Table 139. Abbvie Company Information
Table 140. Abbvie Introduction and Business Overview
Table 141. Abbvie Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2018-2024)
Table 142. Abbvie Antiretroviral Therapy Product
Table 143. Abbvie Recent Development
Table 144. Bionor Pharma Company Information
Table 145. Bionor Pharma Introduction and Business Overview
Table 146. Bionor Pharma Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2018-2024)
Table 147. Bionor Pharma Antiretroviral Therapy Product
Table 148. Bionor Pharma Recent Development
Table 149. Vertex Pharmaceuticals Company Information
Table 150. Vertex Pharmaceuticals Introduction and Business Overview
Table 151. Vertex Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2018-2024)
Table 152. Vertex Pharmaceuticals Antiretroviral Therapy Product
Table 153. Vertex Pharmaceuticals Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Antiretroviral Therapy Market Trends
Table 157. Antiretroviral Therapy Market Drivers
Table 158. Antiretroviral Therapy Market Challenges
Table 159. Antiretroviral Therapy Market Restraints
Table 160. Antiretroviral Therapy Distributors List
Table 161. Antiretroviral Therapy Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Therapy Product Picture
Figure 2. Global Antiretroviral Therapy Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antiretroviral Therapy Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Antiretroviral Therapy Sales Status and Outlook (2018-2034) & (KG)
Figure 5. Product Picture of NNRTIs
Figure 6. Global NNRTIs Sales YoY Growth (2018-2034) & (KG)
Figure 7. Product Picture of NRTI
Figure 8. Global NRTI Sales YoY Growth (2018-2034) & (KG)
Figure 9. Product Picture of Multiclass Combination Products
Figure 10. Global Multiclass Combination Products Sales YoY Growth (2018-2034) & (KG)
Figure 11. Product Picture of Integrase Inhibitors
Figure 12. Global Integrase Inhibitors Sales YoY Growth (2018-2034) & (KG)
Figure 13. Global Antiretroviral Therapy Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Antiretroviral Therapy Sales Market Share by Type in 2022 & 2034
Figure 15. North America Antiretroviral Therapy Sales Market Share in Volume by Type in 2022
Figure 16. North America Antiretroviral Therapy Sales Market Share in Value by Type in 2022
Figure 17. Europe Antiretroviral Therapy Sales Market Share in Volume by Type in 2022
Figure 18. Europe Antiretroviral Therapy Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Antiretroviral Therapy Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Antiretroviral Therapy Sales Market Share in Value by Type in 2022
Figure 21. Latin America Antiretroviral Therapy Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Antiretroviral Therapy Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Antiretroviral Therapy Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Antiretroviral Therapy Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiretroviral Therapy Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiretroviral Therapy Revenue in 2022
Figure 27. Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2034) & (KG)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (KG)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2018-2034) & (KG)
Figure 34. Global Antiretroviral Therapy Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Antiretroviral Therapy Sales Market Share by Application in 2022 & 2034
Figure 36. North America Antiretroviral Therapy Sales Market Share in Volume by Application in 2022
Figure 37. North America Antiretroviral Therapy Sales Market Share in Value by Application in 2022
Figure 38. Europe Antiretroviral Therapy Sales Market Share in Volume by Application in 2022
Figure 39. Europe Antiretroviral Therapy Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Antiretroviral Therapy Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Antiretroviral Therapy Sales Market Share in Value by Application in 2022
Figure 42. Latin America Antiretroviral Therapy Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Antiretroviral Therapy Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Antiretroviral Therapy Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Antiretroviral Therapy Manufacturing Cost Structure
Figure 47. Antiretroviral Therapy Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries